跳到正文
原文
Medical Xpress·· 1 天前AI 评分59

BMJ发布挪威多中心RCT:两种药物促初产妇自然分娩无明确获益

No clear benefit from two drugs intended to increase spontaneous birth after induction in first-time moms

AI 导读

一项在挪威十一家医院开展的多中心随机安慰剂对照 factorial 试验(SAINT)显示,催产启动后给予东莨菪丁溴铵或碳酸氢钠,均未显著提高初产妇自然阴道分娩率。

正文
woman in labor
Credit: Unsplash/CC0 Public Domain

There is no clear evidence that hyoscine butylbromide or sodium bicarbonate improves spontaneous vaginal birth rates (without the assistance of forceps or vacuum) in first-time moms after induction of labor, finds a large Norwegian trial published by The BMJ. Although small benefits of either drug can't be entirely ruled out, the researchers say the findings do not support their routine use.

Women having their first baby after induction of labor have relatively high rates of instrumental and cesarean delivery. Small studies have proposed that hyoscine butylbromide, by relaxing the cervix, and sodium bicarbonate, by improving muscle function, may promote spontaneous vaginal birth.

However, these studies have limitations, and no previous trial has evaluated both drugs after induction of labor and their effects on spontaneous vaginal birth.

To address this, researchers identified 2,963 first-time moms (average age 31 years) due to give birth to a single baby at term and undergoing labor induction at 11 hospitals across Norway between Jan. 4, 2023, and Jan. 29, 2025.

At the onset of active labor, women were randomly assigned to one of four groups: oral sodium bicarbonate plus intravenous hyoscine butylbromide, oral sodium bicarbonate plus intravenous placebo, oral placebo plus intravenous hyoscine butylbromide, or double placebo.

The drugs were repeated every four hours to a maximum of three doses. The main outcome was spontaneous vaginal birth without instrumental or cesarean delivery.

Spontaneous vaginal birth occurred in 57% (422 of 741) in the bicarbonate plus hyoscine butylbromide group, 61% (445 of 734) in the bicarbonate group, 61% (449 of 741) in the hyoscine butylbromide group, and 56% (422 of 747) in the double placebo group.

None of these differences reached the prespecified threshold for statistical significance. However, the authors note that smaller beneficial effects on spontaneous vaginal birth can't be entirely excluded.

Serious adverse events were similar between groups, and no treatment-related serious illness was observed.

The authors acknowledge certain trial limitations. For example, drugs were administered at the onset of active labor irrespective of early labor progression and participants who were not proficient in Norwegian or English were excluded, which may limit generalizability.

However, they say this was a large, nationwide trial where participants, clinical staff, investigators, and outcome assessors were all masked to treatment groups, minimizing the risk of bias, and results were consistent after further analyses, suggesting that they are robust.

As such, they conclude, "Neither agent, alone or in combination, clearly increased spontaneous vaginal birth, although small beneficial effects of either agent could not be excluded. The findings do not support routine intrapartum use of hyoscine butylbromide or sodium bicarbonate after induction of labor."

Publication details

Effect of intrapartum hyoscine butylbromide and sodium bicarbonate on spontaneous vaginal birth in nulliparous women after induction of labour (SAINT): multicentre randomised placebo controlled factorial trial, The BMJ (2026). DOI: 10.1136/bmj-2026-101069

Journal information: British Medical Journal (BMJ)

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: No clear benefit from two drugs intended to increase spontaneous birth after induction in first-time moms (2026, November 18) retrieved 18 November 2026 from https://medicalxpress.com/news/2026-11-benefit-drugs-spontaneous-birth-induction.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com